Total monthly spend depends on the product (semaglutide versus tirzepatide versus another option), the subscription tier, and whether you are dispensed FDA-approved brand medication or a compounded alternative
At our practice in Montgomery County, Maryland, we view these results within the broader context of individualized, whole-person care
Based on current phase 3 TRIUMPH trial timelines, a regulatory submission to the MHRA is not anticipated before 20262027 at the earliest, with a possible marketing authorisation in 20272028 and NHS availability potentially from 2028 onwards, subject to NICE appraisal
Potential benefits of split dosing include reduced GI side effects (lower peak concentration), more consistent appetite suppression throughout the week, and better tolerance at higher doses
A patch, on the other hand, aims to eliminate those peaks and valleys, providing a consistent, unwavering level of the drug